EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The feasibility and acceptability of integrating hepatitis C and HIV diagnostic testing on centralized molecular laboratory platforms in Myanmar

Thandar Su Naing iD, Win Win Yee, Hlaing Thazin Aung, Khin Yi Oo, Khin San Tint, Caroline E Boeke, Yuhui Chan, Magdalena Witschi, Nwe Nwe, Jessica Markby, Sonjelle Shilton iD, Khin Sanda Aung und 3 weitere

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0282585 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Thandar Su Naing und 14 weiteren Autor:innen. Beteiligte Einrichtung: Clinton Health Access Initiative, Yangon, Myanmar. Hauptthemen laut MEDLINE: HIV Infections, Hepatitis C. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Unitaid.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In Myanmar, 1.3 million people have been exposed to hepatitis C (HCV). However, public sector access to viral load (VL) testing for HCV diagnosis remains limited; ten near-point-of-care (POC) devices are available nationally. Myanmar’s National Health Laboratory (NHL) has surplus capacity on centralized molecular testing platforms used for HIV diagnostics, presenting an opportunity for integrating HCV testing to expand overall testing capacity. This pilot assessed the operational feasibility and acceptability of HCV/HIV integrated testing implemented with a comprehensive package of supportive interventions.

Methods

HCV VL samples were collected prospectively from consenting participants at five treatment clinics and tested at Myanmar’s NHL (October 2019-February 2020) on the Abbott m2000. To optimize integration, laboratory human resources were bolstered, staff trainings were offered, and existing laboratory equipment was serviced/repaired as needed. Diagnostics data during the intervention period were compared against HIV diagnostics data in the seven months prior. We conducted three time and motion analyses at the laboratory and semi-structured interviews with laboratory staff to assess time needs and program acceptability.

Results

715 HCV samples were processed during the intervention period with an average test processing time of 18 days (IQR: 8–28). Despite adding HCV testing, average monthly test volumes were 2,331 for HIV VL and 232 for early infant diagnosis (EID), comparable to the pre-intervention period. Processing times were 7 days for HIV VL and 17 days for EID, also comparable to the pre-intervention period. HCV test error rate was 4.3%. Platforms utilization increased from 18.4% to 24.6%. All staff interviewed were supportive of HCV and HIV diagnostics integration; suggestions were made for broader implementation and expansion.

Conclusions

With a package of supportive interventions, integration of HCV and HIV diagnostics on a centralized platform was operationally feasible, did not adversely impact HIV testing, and was acceptable to laboratory staff. In Myanmar, integrated HCV VL diagnostic testing on centralized platforms may be an important addition to existing near-POC testing in expanding national testing capacity for HCV elimination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsHepatitis CInfantHumansMyanmarFeasibility StudiesPoint-of-Care TestingHIV TestingHepacivirusViral Load

Autor:innen und Institutionen

  • Clinton Health Access Initiative, Yangon, Myanmar.
  • National Health Laboratory, Department of Medical Services, Ministry of Health, Yangon, Myanmar.
  • Foundation for Innovative New Diagnostics, Geneva, Switzerland.
  • National Hepatitis Control Program, Department of Public Health, Ministry of Health, Naypyidaw, Myanmar.
  • National AIDS Program, Department of Public Health, Ministry of Health, Naypyidaw, Myanmar.

ORCID-Profile: Thandar Su Naing, Sonjelle Shilton

Förderung

  • Unitaid

Zitieren

APA

Naing, T. S., Yee, W. W., Aung, H. T., Oo, K. Y., Tint, K. S., Boeke, C. E., Chan, Y., Witschi, M., Nwe, N., Markby, J., Shilton, S., Aung, K. S., Oo, H. N., Aye, M. M., & Htay, T. T. (2023). The feasibility and acceptability of integrating hepatitis C and HIV diagnostic testing on centralized molecular laboratory platforms in Myanmar. PLOS ONE. https://doi.org/10.1371/journal.pone.0282585

Vancouver

Naing TS, Yee WW, Aung HT, Oo KY, Tint KS, Boeke CE, et al. The feasibility and acceptability of integrating hepatitis C and HIV diagnostic testing on centralized molecular laboratory platforms in Myanmar. PLOS ONE. 2023. doi:10.1371/journal.pone.0282585

BibTeX
@article{Naing2023,
  author = {Naing, Thandar Su and Yee, Win Win and Aung, Hlaing Thazin and Oo, Khin Yi and Tint, Khin San and Boeke, Caroline E and Chan, Yuhui and Witschi, Magdalena and Nwe, Nwe and Markby, Jessica and Shilton, Sonjelle and Aung, Khin Sanda and Oo, Htun Nyunt and Aye, Moe Myat and Htay, Tin Tin},
  title = {The feasibility and acceptability of integrating hepatitis C and HIV diagnostic testing on centralized molecular laboratory platforms in Myanmar},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0282585}
}
Kostenlos starten →